MDT · Medtronic plc

Healthcare NYQ Ireland medtronic.com ↗
Val Gro Qua Mom Sta Cap P/S3.10 P/E Fwd P/E14.21 PEG1.65 52W –  RSI Target$104.76 (+15.2%) Beta0.57 Div3.11%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Devices Galway, Ireland 95,000 employees
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 51 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
7Bullish
3Bearish
0Neutral

Key Signals 2

▲ Double Bottom Major reversal 2026-07-02 · $81.87
Two lows ~$77.53 — bullish reversal confirmed
Learn more →
▲ Double Bottom Major reversal 2026-07-28 · $85.99
Two lows ~$78.56 — bullish reversal confirmed
Learn more →

Momentum Signals 8

▲ MACD Bullish Crossover 2026-05-18 · $76.63
▲ MACD Bullish Crossover 2026-06-03 · $77.25
▲ Bull Flag 2026-07-02 · $81.87
▲ MACD Bullish Crossover 2026-07-16 · $83.56

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 17, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +15.2%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
20
9
BuyHoldSell
Price Target Range
$104.76 +15.2% upside
Low $85 High $121
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 65.27%Last 12 Months
Operating Margin 19.33%Last 12 Months
Return on Equity 10.65%Last 12 Months
Revenue Growth 13.70%Year over Year
Free Cash Flow 5.41BLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 55.37Most Recent Quarter
Current Ratio 2.07Most Recent Quarter
Cash 8.82BMost Recent Quarter
Total Debt 28.15BMost Recent Quarter
Net Debt Most Recent Quarter
How MDT Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap116.35B
Enterprise Value136.30B
Trailing P/E22.57
Forward P/E14.21
PEG Ratio (5yr)1.65
Price/Sales (ttm)3.10
Price/Book (mrq)2.32
EV/Revenue3.63
EV/EBITDA13.10
Share Statistics
Avg Vol (3m)8.11M
Shares Outstanding1.28B
Float1.28B
% Held by Insiders0.39%
% Held by Institutions88.66%
Short Ratio1.74
Short % of Float0.95%
Profitability
Gross Margin65.27%
Operating Margin (ttm)19.33%
Profit Margin13.93%
Return on Assets (ttm)5.12%
Return on Equity (ttm)10.65%
Income Statement
Revenue (ttm)37.54B
Revenue Growth (yoy)13.70%
Gross Profit (ttm)24.50B
EBITDA10.41B
Net Income (ttm)5.23B
Diluted EPS (ttm)4.03
EPS Growth (yoy)40.70%
Balance Sheet
Total Cash (mrq)8.82B
Total Debt (mrq)28.15B
Debt / Equity (mrq)55.37
Current Ratio (mrq)2.07
Book Value / Share39.24
Operating CF (ttm)8.03B
Free Cash Flow (ttm)5.41B
Trading & Dividends
Beta (5Y)0.57
50-Day MA87.45
200-Day MA89.60
Fwd Dividend Yield3.14%
Payout Ratio70.20%
Income
Dividend Yield 3.11%Last 12 Months
Annual Rate 2.88Forward
Payout Ratio 70.20%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 70.20%
Monthly Dividends
Ownership Breakdown
Institutional 88.66% Insider 0.39% Public 11.0%
Short Interest 0.95% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in MDT in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value